This site requires javascript. Please turn that on in your browser\'s preferences. How?

Apex IONM Solutions Apex IONM Solutions

Treatment of New-Onset Epilepsy: AAN, AES Update Practice Guidelines

By Admin | September 04, 2018

The American Academy of Neurology (AAN) and the American Epilepsy Society (AES) have provided new recommended practice guidelines for the management of new-onset and treatment-resistant epilepsy with anti-epileptic drugs (AEDs).1,2 The new guidelines highlight the evidence supporting the use of lamotrigine, vigabatrin, levetiracetam, pregabalin, gabapentin, and zonisamide for reducing the frequency of seizures in new-onset focal epilepsy and treatment-resistant epilepsy.

An expert subcommittee was formed consisting of members of the AAN and AES to update the 2004 evidence-based guidelines on epilepsy treatment with AEDs. Based on recent evidence, the investigators recommend the use of gabapentin and topiramate in adults and children with newly diagnosed epilepsy.

For more information, please read, Treatment of New-Onset Epilepsy: AAN, AES Update Practice Guidelines, by Neurology Advisor. 

 

« Return to ALL NEWS